White label ELPA - ClinicalTrials.eu

Study on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis

Not recruiting

4 1
Investigated diseases:
- Idiopathic pulmonary fibrosis
Investigated drugs:
- Bexotegrast
+5
Study of Baricitinib and Adalimumab for Children Aged 2 to 17 with Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Not recruiting

3 1 1 1
Investigated drugs:
- Adalimumab
- Baricitinib
Study on the Effectiveness and Safety of Obinutuzumab and Mycophenolate Mofetil in Children with Idiopathic Nephrotic Syndrome

Not recruiting

3 1 1 1
Investigated diseases:
- Nephrotic syndrome
Investigated drugs:
- Mycophenolate Mofetil
- Obinutuzumab
Study of XXB750 and Drug Combination for Patients with Heart Failure

Not recruiting

2 1 1
Investigated diseases:
- Cardiac failure
Investigated drugs:
+5
Long-term Safety Study of Etranacogene Dezaparvovec in Adult Men with Hemophilia B

Not recruiting

4 1 1 1
Investigated diseases:
- Factor IX deficiency
Investigated drugs:
- Etranacogene Dezaparvovec
Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Ulcerative Colitis

Not recruiting

3 1
Investigated diseases:
- Colitis ulcerative
Investigated drugs:
- Guselkumab
+2
Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

Not recruiting

2 1
Investigated diseases:
- Rheumatoid arthritis
Investigated drugs:
- Rosnilimab
+3
Study on the Safety and Effects of Livmoniplimab and Budigalimab in Patients with Advanced or Metastatic Solid Tumors

Not recruiting

1 1 1
Investigated drugs:
- Budigalimab
- Livmoniplimab
Study on the Effectiveness and Safety of Obinutuzumab and Tacrolimus for Patients with Primary Membranous Nephropathy

Not recruiting

3 1 1 1
Investigated diseases:
- Glomerulonephritis membranous
Investigated drugs:
- Obinutuzumab
- Tacrolimus
Study on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer’s Disease

Not recruiting

2 1 1
Investigated diseases:
- Dementia Alzheimer’s type
Investigated drugs:
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies